⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Seattle Children's and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Seattle Children's
↗Seattle, USA
Seattle Children's is a premier pediatric academic medical center and research institution serving the Pacific Northwest (Washington, Alaska, Montana, and Idaho). It is deeply integrated with the University of Washington School of Medicine for teaching and research.
The organization operates the Seattle Children's Research Institute, which hosts a robust, non-profit, in-house biotech enterprise known as Seattle Children's Therapeutics. This division focuses on translating scientific discoveries into clinical therapies, with a strong emphasis on cell and gene therapies, particularly CAR T-cell immunotherapy for pediatric cancers and blood disorders.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Pediatric Oncology, Cell & Gene Therapy, Rare Disease
SIZE & FINANCIALS
Employees:5001-10000
Founded:1907
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Cell therapy, Gene therapy, CAR T-cell
Active Trials:345
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University of Washington (Academic/Clinical), Fred Hutch Cancer Center (Clinical), CSL Behring (Gene Therapy collaboration), CureWorks (Pediatric immunotherapy collaborative)
COMPETITION
Position:Leader
LINKS
Website:seattlechildrens.org
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Seattle Children's. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.